一项务实随机对照试验:保留Retzius间隙入路对机器人辅助根治性前列腺切除术后早期尿控恢复的影响
该单中心随机对照试验将120例低中危前列腺癌患者随机分为后入路(保留Retzius间隙)组60例与前入路(标准)组60例,比较术后3个月内尿控与排尿功能。结果显示后入路组拔管后1周尿控率71% vs 前入路组48%(p=0.01),中位尿控时间2天 vs 8天(log-rank p=0.02),排尿功能相关困扰评分更低。
要点
- 后入路组拔管后1周尿控率71%,前入路组48%(p=0.01)。
- 后入路组中位尿控时间2天,前入路组8天(log-rank p=0.02)。
- 两组术后并发症发生率与无生化复发生存概率相当。
核心结论
- 在单中心随机研究中,保留Retzius间隙入路的机器人辅助根治性前列腺切除术较标准入路尿控恢复更早、排尿功能相关困扰更低。
- 作者认为这些结果需长期验证、其他中心重复,并需在高危局限性疾病男性中研究。
研究设计与样本
- 单中心随机对照试验,纳入120例40-75岁低中危前列腺癌患者,随机分为后入路组60例与前入路组60例。
主要发现
- 拔管后1周尿控率后入路组71% vs 前入路组48%(p=0.01)。
- 拔管后1周中位24小时尿垫重量后入路组5g vs 前入路组25g(p=0.001)。
- 拔管后中位尿控时间后入路组2天 vs 前入路组8天(log-rank p=0.02)。
- 排尿功能相关困扰评分在后入路组于拔管后1周、2周和1个月显著低于前入路组,排尿功能评分无显著差异。
- 术后并发症发生率前入路组12% vs 后入路组18%,无生化复发生存概率两组均为0.91。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者指出结果为单中心研究,需长期验证和其他中心重复。
- 作者指出需在高危局限性疾病男性中开展研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Retzius-sparing (posterior) robot-assisted radical prostatectomy (RARP) may expedite postoperative urinary continence recovery. OBJECTIVE: To compare the short-term (≤3 mo) urinary continence (UC), urinary function (UF), and UF-related bother outcomes of posterior RARP compared with standard anterior approach RARP. DESIGN, SETTING, AND PARTICIPANTS: A total of 120 patients aged 40-75 yr with low-intermediate-risk prostate cancer (per the National Comprehensive Cancer Network guidelines) underwent primary RARP at a tertiary care institution. INTERVENTION: Eligible men were randomized to receive either posterior (n=60) or anterior (n=60) RARP. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSES: Primary outcome was UC (defined as 0 pads/one security liner per day) 1 week after catheter removal. Secondary outcomes were short-term (≤3 mo) UC recovery, and UF and UF-related bother scores (measured by the International Prostate Symptom Score [IPSS] and IPSS quality-of-life scores, respectively) assessed at 1 and 2 wk, and 1 and 3 mo following catheter removal. Continence outcomes were objectively verified using 24-hr pad weights. UC recovery was analyzed using Kaplan-Meier method and Cox proportional hazards regression; UF and UF-related bother outcomes were compared using linear generalized estimating equations (GEEs). Perioperative complications, positive surgical margin, and biochemical recurrence-free survival (BCRFS) represent secondary outcomes reported in the study. RESULTS AND LIMITATIONS: Compared with 48% in the anterior arm, 71% men undergoing posterior RARP were continent 1 wk after catheter removal (p=0.01); corresponding median 24-h pad weights were 25 and 5g (p=0.001). Median time to continence in posterior versus anterior RARP was 2 and 8 d postcatheter removal, respectively (log-rank p=0.02); results were confirmed on multivariable regression analyses. GEE analyses showed that UF-related bother (but not UF) scores were significantly lower in the posterior versus anterior RARP group at 1 wk, 2 wk, and 1 mo on GEE analyses. Incidence of postoperative complications (12% anterior vs 18% posterior) and probability of BCRFS (0.91 vs 0.91) were comparable in the two arms. CONCLUSIONS: In this single-center randomized study, the Retzius-sparing approach of RARP resulted in earlier recovery of UC and lower UF-related bother compared with standard RARP. These results require long-term validation and reproduction by other centers, as well as studies on men with high-risk localized disease. PATIENT SUMMARY: In our hands, men with low-intermediate-risk prostate cancer undergoing Retzius-sparing robot-assisted radical prostatectomy (RARP) had earlier recovery of urinary continence and lower urinary function-related bother than those undergoing standard RARP.
引用
- Dalela D, Jeong W, Prasad MA, et al. A Pragmatic Randomized Controlled Trial Examining the Impact of the Retzius-sparing Approach on Early Urinary Continence Recovery After Robot-assisted Radical Prostatectomy. Eur Urol. 2017. PMID: 28483330. doi:10.1016/j.eururo.2017.04.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。